RICHARD KLAUSNER

[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”1_4″][et_pb_image admin_label=”Image” src=”http://www.pmwcintl.xyz/wp-content/uploads/2016/04/Klausner.jpg” show_in_lightbox=”off” url_new_window=”off” use_overlay=”off” animation=”left” sticky=”off” align=”center” force_fullwidth=”off” always_center_on_mobile=”on” use_border_color=”off” border_color=”#ffffff” border_style=”solid”] [/et_pb_image][/et_pb_column][et_pb_column type=”3_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]

RICHARD KLAUSNER

M.D., CHIEF MEDICAL OFFICER & INTERIM GENERAL MANAGER, ONCOLOGY, ILLUMINA

Dr. Klausner is SVP & CMO of Illumina. He is Founder/Director of Juno Therapeutics. He was Executive Director for Global Health Bill and Melinda Gates Foundation, was the 11th Director of the National Cancer Institute from 1995 – 2001 and served in senior advisory roles to the US, Norwegian, Qatari and Indian governments. Dr. Klausner is known for his work in cell/molecular biology, received numerous awards, honors and served as an Advisor to Presidents of Academies for counter-terrorism, and Liaison to the White House Office of Science & Technology Policy.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]